Pediatric Cancer Care

Find a Pediatric Clinical Trial

Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our list of clinical trials that are currently enrolling new pediatric patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

Showing 1 - 20 of 84 trials
Titlesort icon Investigator Disease(s)
A Phase I Study of Actinium-225-Labeled HuM195 Antibody in Patients with Advanced Myeloid Malignancies
[Protocol 02-017] 		Douer, Dan
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229] 		Young, James
  • Melanoma
A Phase I Study of Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
[Protocol 09-011] 		Modak, Shakeel
  • Neuroblastoma
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
[Protocol 12-151] 		Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of Blinatumomab in Children and Adolescents with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-044] 		Trippett, Tanya
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of Cabazitaxel in Children and Teens with Persistent Solid Tumors
[Protocol 13-021] 		Trippett, Tanya
  • Pediatric Brain Tumors
    • CNS Cancer
  • Primary Bone
  • Sarcomas
  • Solid Tumors
A Phase I Study of Convection-Enhanced Delivery of 124I-8H9 for Patients with Non-Progressive Diffuse Pontine Gliomas Previously Treated with Radiation Therapy
[Protocol 11-011] 		Souweidane, Mark
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of Genetically Modified T Cells Targeting CD19 in Pediatric and Young Adult Patients with Relapsed B-Cell Acute Lymphoblastic Leukemia
[Protocol 13-052] 		Curran, Kevin
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 11-009] 		Basu, Ellen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 12-116] 		Roberts, Stephen
  • Neuroblastoma
  • Sarcomas
    • Osteosarcoma
    • Soft Tissue Sarcoma
A Phase I Study of Intraperitoneal Radioimmunotherapy with 131I-8H9 for Patients with Desmoplastic Small Round Cell Tumors and Other Solid Peritoneal Tumors
[Protocol 09-090] 		Modak, Shakeel
A Phase I Study of Intrathecal Radioimmunotherapy Using 131I-8H9 for Central Nervous System/Leptomeningeal Cancers
[Protocol 03-133] 		Kramer, Kim
  • Brain Tumors, Primary
  • Neuroblastoma
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase I Study of Ipilimumab in Children, Adolescents, and Young Adults with Treatment-Refractory Cancer
[Protocol 10-193] 		Wexler, Leonard
  • Lymphoma
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
  • Melanoma
  • Sarcomas
A Phase I Study of Modified T Cells Targeted to CD19-Positive Acute Lymphoblastic Leukemia Relapsing After Allogeneic Stem Cell Transplantation
[Protocol 11-038] 		Kernan, Nancy
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of Panitumumab in Children with Solid Tumors
[Protocol 08-020] 		Meyers, Paul
A Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
[Protocol 08-091] 		Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
[Protocol 12-230] 		Kushner, Brian
  • Neuroblastoma
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198] 		Pratilas, Christine
  • Melanoma
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055] 		O'Reilly, Richard
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075] 		Kushner, Brian
  • Neuroblastoma